Editorial Foreword || FREE PAPER ||

Roger M Pinder

Pharma Consultant, ´s-Hertogenbosch, The Netherlands

New journals generally face a difficult gestation. Finding publishers, appointing editors, recruiting Editorial Board members, calling for manuscripts, selecting peer-reviewers who will deliver on time and finding substitutes when they do not; and all of this without accreditation at the major medical indexes, making authors understandably reluctant to commit their best work when it cannot yet be cited.¹  Neuropsychiatric Disease and Treatment (NDT) is no exception, but did have the good fortune that publisher Dove Medical Press was available and fully supportive.